Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06575868 · ClinicalTrials.gov registry record · NA

Myo-inositol During Pregnancy to Prevent Gestational Diabetes

A NA study of Pregnancy Related, sponsored by Tufts Medical Center.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06575868: Recruiting NA study of Pregnancy Related, sponsored by Tufts Medical Center.

NCT06575868 is a NA study of Pregnancy Related that is actively recruiting participants, run by Tufts Medical Center. The registered enrollment target is 40 participants, below the 1,963-participant average among 99 other Pregnancy Related trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06575868, a NA study of Pregnancy Related, is actively recruiting participants, sponsored by Tufts Medical Center.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Myoinositol is an insulin-like compound that is present in both plant and animal cells. Humans synthesize it naturally, but it is also obtained in our diet. It works through an intracellular signaling pathway to increase insulin sensitivity. Myoinositol has been used as an over-the-counter (OTC) supplement in the management of polycystic ovarian syndrome due to this effect. Myoinositol has also been shown to improve glycemic profiles in pregnant euglycemic women and well as improve insulin sensitivity in pregnant patients with gestational diabetes mellitus (GDM). This is a double blind RCT offering myo-inositol or placebo to those who are eligible and enrolled.

Primary Outcome

proportion of screened women who were eligible

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Myo-inositol
  • DIETARY_SUPPLEMENT Myo-inositol placebo

Study Locations (1)

Massachusetts

  • Tufts Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-03-01
Est. Completion 2027-06-30
Phase NA
Tufts Medical Center

169 total trials

What NCT06575868 shows while recruiting

NCT06575868 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,963-participant average among 99 other Pregnancy Related trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Pregnancy Related appearing as the primary indexed condition, and to 2 interventions - of which Myo-inositol is the first listed.

NCT06575868 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06575868 about?

NCT06575868 is a clinical study titled "Myo-inositol During Pregnancy to Prevent Gestational Diabetes". Myoinositol is an insulin-like compound that is present in both plant and animal cells. Humans synthesize it naturally, but it is also obtained in our diet. It works through an intracellular signaling pathway to increase insulin sensitivity. Myoinositol has been used as an over-the-counter (OTC) sup...

What is the current status of trial NCT06575868?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-03-01. Estimated completion is 2027-06-30.

What conditions does trial NCT06575868 study?

This clinical trial studies the following conditions: Pregnancy Related.

What interventions are being tested in trial NCT06575868?

The interventions under investigation include: Myo-inositol (DIETARY_SUPPLEMENT), Myo-inositol placebo (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06575868?

This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06575868 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy Related

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06575868's enrollment target sits among peer trials

40 83rd of 99 higher than 15 of 99 other Pregnancy Related trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06575868, the US trial registry maintained by the National Library of Medicine. NCT06575868 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.